U.S. flag

An official website of the United States government

NM_001100.4(ACTA1):c.541del (p.Asp181fs) AND Actin accumulation myopathy

Germline classification:
Pathogenic/Likely pathogenic (2 submissions)
Last evaluated:
Oct 6, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001384035.9

Allele description [Variation Report for NM_001100.4(ACTA1):c.541del (p.Asp181fs)]

NM_001100.4(ACTA1):c.541del (p.Asp181fs)

Gene:
ACTA1:actin alpha 1, skeletal muscle [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
1q42.13
Genomic location:
Preferred name:
NM_001100.4(ACTA1):c.541del (p.Asp181fs)
Other names:
NM_001100.4(ACTA1):c.541del; p.Asp181fs
HGVS:
  • NC_000001.11:g.229432346del
  • NG_006672.1:g.6752del
  • NG_093760.1:g.731del
  • NM_001100.4:c.541delMANE SELECT
  • NP_001091.1:p.Asp181Thrfs
  • NP_001091.1:p.Asp181fs
  • NP_001091.1:p.Asp181fs
  • LRG_429t1:c.541del
  • LRG_429:g.6752del
  • LRG_429p1:p.Asp181fs
  • NC_000001.10:g.229568092del
  • NC_000001.10:g.229568093del
  • NM_001100.3:c.540delG
  • NM_001100.3:c.541del
  • NM_001100.3:c.541delG
Protein change:
D181fs
Links:
OMIM: 102610.0022; dbSNP: rs759242559
NCBI 1000 Genomes Browser:
rs759242559
Molecular consequence:
  • NM_001100.4:c.541del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Actin accumulation myopathy (CMYO2A)
Synonyms:
Nemaline myopathy caused by mutation in the alpha-actin gene; CONGENITAL MYOPATHY 2A, TYPICAL, AUTOSOMAL DOMINANT; Myopathy, actin, congenital, with cores; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0008070; MedGen: C3711389; OMIM: 161800

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001583399Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Oct 6, 2023)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

SCV003761240Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Jan 25, 2023)
germlinecuration

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing, curation

Citations

PubMed

Mutations and polymorphisms of the skeletal muscle alpha-actin gene (ACTA1).

Laing NG, Dye DE, Wallgren-Pettersson C, Richard G, Monnier N, Lillis S, Winder TL, Lochmüller H, Graziano C, Mitrani-Rosenbaum S, Twomey D, Sparrow JC, Beggs AH, Nowak KJ.

Hum Mutat. 2009 Sep;30(9):1267-77. doi: 10.1002/humu.21059.

PubMed [citation]
PMID:
19562689
PMCID:
PMC2784950

Nemaline myopathy caused by absence of alpha-skeletal muscle actin.

Nowak KJ, Sewry CA, Navarro C, Squier W, Reina C, Ricoy JR, Jayawant SS, Childs AM, Dobbie JA, Appleton RE, Mountford RC, Walker KR, Clement S, Barois A, Muntoni F, Romero NB, Laing NG.

Ann Neurol. 2007 Feb;61(2):175-84.

PubMed [citation]
PMID:
17187373
See all PubMed Citations (4)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001583399.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This sequence change creates a premature translational stop signal (p.Asp181Thrfs*11) in the ACTA1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ACTA1 are known to be pathogenic (PMID: 19562689). This variant is present in population databases (rs759242559, gnomAD 0.03%). This premature translational stop signal has been observed in individuals with autosomal recessive congenital myopathy (PMID: 17187373). ClinVar contains an entry for this variant (Variation ID: 420100). For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard, SCV003761240.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcuration PubMed (1)

Description

The homozygous p.Asp181ThrfsTer11 variant in ACTA1 was identified by our study in one individual with nemaline myopathy. The p.Asp181ThrfsTer11 variant in ACTA1 has been previously reported in four individuals with autosomal recessive nemaline myopathy (PMID: 17187373) but has been identified in 0.03% (10/30614) of South Asian chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs759242559). Although this variant has been seen in the general population in a heterozygous state, its frequency is not high enough to rule out a pathogenic role. Of these four affected individuals previously reported, all (four) were homozygotes, which increases the likelihood that the p.Asp181ThrfsTer11 variant is pathogenic. This variant has also been reported in ClinVar (Variation ID:420100) and has been interpreted as pathogenic by GeneDx, Invitae, and PerkinElmer Genomics. This variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at position 181 and leads to a premature termination codon 11 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Loss of function of the ACTA1 gene is an established disease mechanism in autosomal recessive nemaline myopathy. In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic for autosomal recessive nemaline myopathy. ACMG/AMP Criteria applied: PVS1, PM3 (Richards 2015).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 13, 2024